Ramucirumab for Patients with Advanced Hepatocellular Carcinoma and Elevated Alpha Fetoprotein Following Non-Sorafenib Systemic Therapy: An Expansion Cohort of REACH-2
Related Posts
Palermo TM, Li R, Zhou C, Aalfs H, Cress G, Lowe M, Abu-El-Haija M, Chugh A, Downs EM, Fishman DS, Freeman AJ, Giefer MJ, Gonska[...]
Plasma proteomic profiles identify biomarkers predicting Crohn’s disease up to 16 years before onset
Feng J, Chen S, Li Q, Long Y, Ma Y, Zhang L, Zeng R, Luo D, Meng M, Yu S, Chen C, Wu Y, Huang[...]
Yang HJ, Corson M, Aja E, Spartz E, Limketkai BN, Jacobs JP. Protein-Calorie Malnutrition Is Associated with Altered Colonic Mucosal Microbiota in Inflammatory Bowel Disease.[...]